Novo Nordisk A/S
Novo Nordisk shares fall 6.3% after latest trial results for its next-generation weight loss drug
Medical bottles and syringe are seen with Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Shares of Novo Nordisk fell on Monday, after the Danish pharmaceutical giant said its next-generation weight-loss drug CagriSema helped obese or overweight adult patients with type 2 diabetes drop 15.7% of their […]
Read More
Stocks making the biggest moves midday: General Motors, Novo Nordisk, Kenvue, CrowdStrike and more
Check out the companies making headlines in midday trading: Box — Shares declined more than 3% after the cloud storage company’s top-line guidance fell short of estimates. Box sees first-quarter revenue coming in between $274 million and $275 million, while analysts polled by LSEG expected $279.5 million. Box’s fourth-quarter revenue of $280 million exceeded Wall […]
Read More
Stocks making the biggest moves midday: General Motors, Novo Nordisk, Kenvue, CrowdStrike and more
Check out the companies making headlines in midday trading: Box — Shares declined more than 3% after the cloud storage company’s top-line guidance fell short of estimates. Box sees first-quarter revenue coming in between $274 million and $275 million, while analysts polled by LSEG expected $279.5 million. Box’s fourth-quarter revenue of $280 million exceeded Wall […]
Read More
Novo Nordisk offers Wegovy for less than half the price through new direct-to-consumer pharmacy
Novo Nordisk’s Wegovy weight loss drug has seen a meteoric rise in popularity. Nurphoto | Getty Images Novo Nordisk on Wednesday said it will offer its weight loss drug Wegovy for less than half of its usual price per month through a new direct-to-consumer online pharmacy. The cash-pay offering is available to millions of patients […]
Read More
Amgen starts two critical late-stage trials for weight loss drug MariTide
The Amgen logo is displayed outside Amgen headquarters in Thousand Oaks, California, on May 17, 2023. Mario Tama | Getty Images Amgen on Wednesday said it has started two critical late-stage trials for its experimental weight loss injection MariTide, another step in its bid to enter the booming obesity drug market. “We’re delighted to share […]
Read More
Healthy Returns: AbbVie is the newest potential weight loss drug market player
A sign stands outside an Abbvie facility in Cambridge, Massachusetts. Brian Snyder | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The booming weight loss drug market has gained a new potential competitor. AbbVie […]
Read More
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Wednesday said it will invest at least $27 billion to build four new manufacturing sites in the U.S., as demand for its blockbuster weight loss and diabetes […]
Read More
Eli Lilly plans at least $27 billion in new U.S. manufacturing investments
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Wednesday said it will invest at least $27 billion to build four new manufacturing sites in the U.S., as demand for its blockbuster weight loss and diabetes […]
Read More
Stocks making the biggest moves midday: UnitedHealth, Alibaba, Hims & Hers Health, Celsius and more
Check out the companies making headlines in midday trading: Novo Nordisk — Shares rose 4.9% after the Food and Drug Administration said Friday that the U.S. shortage of Novo Nordisk’s weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than two years. Hims & Hers Health — The telehealth stock, which offers compounded Wegovy and […]
Read More
Shortage of Novo Nordisk’s Wegovy and Ozempic drugs is resolved, FDA says
Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie Adams | Reuters The long-running U.S. shortage of Novo Nordisk‘s blockbuster weight loss injection Wegovy and diabetes treatment Ozempic is resolved after more than two years, the Food and Drug Administration said on Friday. The FDA’s decision will threaten the […]
Read More